[CBAY] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 9.11%
YoY- -21.89%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 31,016 0 0 0 0 0 0 -
PBT -808 -28,778 -26,633 -24,505 -27,094 -27,769 -26,543 -90.31%
Tax 5,900 6,306 9,748 3,142 3,325 3,267 5,139 9.67%
NP -808 -35,084 -36,381 -27,647 -30,419 -31,036 -26,543 -90.31%
Tax Rate - - - - - - - -
Total Cost 31,824 35,084 36,381 27,647 30,419 31,036 26,543 12.89%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -2.61 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.01 -0.36 -0.41 -0.33 -0.36 -0.36 -0.38 -91.21%
EPS Diluted -0.01 -0.36 -0.41 -0.31 -0.35 -0.35 -0.38 -91.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.